bioAffinity Technologies, Inc. ( BIAF) - Key Metrics
BIAF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.34 | -$9.66 | -$9.19 | -$9.44 |
| 2026Q1 | $4.51 | -$12.12 | -$10.77 | -$10.79 |
| 2025Q4 | $13.88 | -$27.34 | -$22.31 | -$21.78 |
| 2025Q3 | $20.34 | -$71.05 | -$34.89 | -$34.84 |
| 2025Q2 | $23.78 | -$76.07 | -$49.59 | -$49.84 |
BIAF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.32 |
| 2026Q1 | 0% | -1.18 |
| 2025Q4 | 0% | -0.16 |
| 2025Q3 | 0% | -0.16 |
| 2025Q2 | 0% | -0.43 |
BIAF
Price: $15.27
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 6.4 million